Metlife Share Price (NYSE: MET)

$81.3

▲

2.06

(2.6%)

Live

Last updated on August 23, 2025 at 12:37 AM IST

$₹

Check the interactive Metlife Stock chart to analyse performance

Metlife stock performance

as on August 23, 2025 at 12:37 AM IST

Today's Low:$80.08
Today's High:$81.87
$81.30
1.5%
Downside
Day's Volatility :2.19%
Upside
0.7%
52 Weeks Low:$65.21
52 Weeks High:$89.05
$81.30
19.79%
Downside
52 Weeks Volatility :26.77%
Upside
8.7%

Metlife Stock Returns

Period	Metlife, Inc.	Sector (Financials)	Index (Russel 2000)
3 Months	2.6%	4.9%	0.0%
6 Months	-2.22%	3.8%	0.0%
1 Year	7.26%	19.6%	0.0%
3 Years	20.63%	54.1%	-7.7%

Metlife, Inc. Key Stats

Check Metlife key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$79.24
Open	$79.07
Today's High	$81.87
Today's Low	$80.08
Market Capitalization	$52.6B
Today's Volume	$2.0M
52 Week High	$89.05
52 Week Low	$65.21
Revenue TTM	$73.0B
EBITDA	$7.2B
Earnings Per Share (EPS)	$5.89
PE Ratio	13.42
Dividend Yield	2.8%
Profit Margin	5.87%
Quarterly Earnings Growth YOY	-0.19%
Return On Equity TTM	15.51%

Stock Returns calculator for Metlife Stock including INR - Dollar returns

The Metlife stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Metlife investment value today

Current value as on today

₹1,14,369

Returns

₹14,369

(+14.37%)

Returns from Metlife Stock

₹10,088 (+10.09%)

Dollar Returns*

₹4,281 (+4.28%)

Indian investors sentiment towards Metlife Stock

100%

Period: Jul 22, 2025 to Aug 21, 2025. Change in 30 Days versus previous period

Search interest for Metlife Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Metlife Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	4558	-21.97	0.08%

Global Institutional Holdings in Metlife, Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
8.60%
Dodge & Cox
8.00%
BlackRock Inc
7.06%
State Street Corp
4.03%
T. Rowe Price Associates, Inc.
3.04%
Geode Capital Management, LLC
1.95%

Analyst Recommendation on Metlife Stock

Rating

Trend

Buy

75%Buy

25%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Metlife(by analysts ranked 0 to 5 stars)

Metlife Share Price Target

What analysts predicted

Upside of 12.9%

Target:

$91.79

Current:

$81.30

Metlife share price target is $91.79, a slight Upside of 12.9% compared to current price of $81.30 as per analysts' prediction.

Metlife Stock Insights

Price Movement
In the last 7 days, MET stock has moved up by 2.4%
Decreasing Revenue
Metlife, Inc. has experienced a decline in revenue for the last three quarters. Specifically, the company's revenue decreased from $18.66 billion to $17.16 billion. This represents an average decrease of 4.0% per quarter.
Decreasing Net Profit
Metlife, Inc. has experienced a decline in net profit over the last four quarters. Specifically, the net profit decreased from $1.34 billion to $729 million, resulting in an average decline of 17.9% each quarter.
MET vs UNM (1 yr)
In the last 1 year, Unum Group has given 28.3% return, outperforming this stock by 21.0%
MET vs UNM (3 yr)
In the last 3 years, Unum Group has given 77.9% return, outperforming this stock by 57.7%
Price to Sales
Metlife, Inc. has a Price-to-Sales Ratio of 0.7, meaning that investors are willing to pay $0.70 for every $1 of sales generated by the company. In comparison, Unum Group has a higher Price-to-Sales Ratio of 1.0, indicating that investors pay $1.00 for each $1 of sales. This suggests that investors value Metlife's sales relatively lower than Unum Group's.

Metlife, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$69.6B	↑ 2.47%
Net Income	$5.9B	↑ 15.15%
Net Profit Margin	8.47%	↑ 0.93%

	FY20	Y/Y Change
Revenue	$67.9B	↓ 2.49%
Net Income	$5.4B	↓ 8.34%
Net Profit Margin	7.96%	↓ 0.51%

	FY21	Y/Y Change
Revenue	$63.3B	↓ 6.72%
Net Income	$6.9B	↑ 26.78%
Net Profit Margin	10.82%	↑ 2.86%

	FY22	Y/Y Change
Revenue	$68.8B	↑ 8.59%
Net Income	$5.3B	↓ 22.92%
Net Profit Margin	7.68%	↓ 3.14%

	FY23	Y/Y Change
Revenue	$66.9B	↓ 2.71%
Net Income	$1.6B	↓ 70.14%
Net Profit Margin	2.36%	↓ 5.32%

	FY24	Y/Y Change
Revenue	$71.0B	↑ 6.1%
Net Income	$4.4B	↑ 180.48%
Net Profit Margin	6.24%	↑ 3.88%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$16.1B	↓ 15.61%
Net Income	$867.0M	↑ 42.83%
Net Profit Margin	5.4%	↑ 2.21%

	Q2 FY24	Q/Q Change
Revenue	$17.8B	↑ 11.0%
Net Income	$946.0M	↑ 9.11%
Net Profit Margin	5.31%	↓ 0.09%

	Q3 FY24	Q/Q Change
Revenue	$18.4B	↑ 3.46%
Net Income	$1.3B	↑ 41.86%
Net Profit Margin	7.28%	↑ 1.97%

	Q4 FY24	Q/Q Change
Revenue	$18.7B	↑ 1.2%
Net Income	$1.3B	↓ 5.29%
Net Profit Margin	6.81%	↓ 0.47%

	Q1 FY25	Q/Q Change
Revenue	$18.6B	↓ 0.5%
Net Income	$945.0M	↓ 25.65%
Net Profit Margin	5.09%	↓ 1.72%

	Q2 FY25	Q/Q Change
Revenue	$17.2B	↓ 7.59%
Net Income	$729.0M	↓ 22.86%
Net Profit Margin	4.25%	↓ 0.84%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$16.2B	↑ 1.82%

	FY20	Y/Y Change
Profit	$15.5B	↓ 4.45%

	FY21	Y/Y Change
Profit	$16.8B	↑ 8.58%

	FY22	Y/Y Change
Profit	$18.8B	↑ 11.89%

	FY23	Y/Y Change
Profit	$16.0B	↓ 14.93%

	FY24	Y/Y Change
Profit	$19.0B	↑ 18.58%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$4.5B	↑ 41.52%

	Q2 FY24	Q/Q Change
Profit	$4.4B	↓ 2.52%

	Q3 FY24	Q/Q Change
Profit	$5.4B	↑ 23.48%

	Q4 FY24	Q/Q Change
Profit	$4.8B	↓ 11.23%

	Q1 FY25	Q/Q Change
Profit	$4.7B	↓ 1.21%

	Q2 FY25	Q/Q Change
Profit	$4.5B	↓ 4.6%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$13.8B	↑ 44.72%
Investing Cash Flow	$-17.6B	↑ 212.14%
Financing Cash Flow	$4.6B	↓ 263.08%

	FY20	Y/Y Change
Operating Cash Flow	$11.6B	↓ 15.57%
Investing Cash Flow	$-18.6B	↑ 5.59%
Financing Cash Flow	$10.7B	↑ 134.87%

	FY21	Y/Y Change
Operating Cash Flow	$12.6B	↑ 8.22%
Investing Cash Flow	$-11.2B	↓ 39.75%
Financing Cash Flow	$-1.4B	↓ 112.82%

	FY22	Y/Y Change
Operating Cash Flow	$13.2B	↑ 4.83%
Investing Cash Flow	$-2.6B	↓ 76.58%
Financing Cash Flow	$-10.1B	↑ 635.13%

	FY23	Y/Y Change
Operating Cash Flow	$14.3B	↑ 8.0%
Investing Cash Flow	$-10.2B	↑ 291.07%
Financing Cash Flow	$-2.9B	↓ 70.91%

	FY24	Y/Y Change
Operating Cash Flow	$15.1B	↑ 6.0%
Investing Cash Flow	$-11.5B	↑ 12.17%
Financing Cash Flow	$-3.1B	↑ 6.5%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$2.3B	↓ 59.31%
Investing Cash Flow	$-2.6B	↓ 556.08%
Financing Cash Flow	$-261.0M	↑ 48.3%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$3.5B	↑ 49.91%
Investing Cash Flow	$-1.3B	↓ 48.99%
Financing Cash Flow	$-1.2B	↑ 361.69%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$4.2B	↑ 19.46%
Investing Cash Flow	$-2.2B	↑ 61.34%
Financing Cash Flow	$-1.1B	↓ 4.9%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$5.1B	↑ 23.03%
Investing Cash Flow	$-5.4B	↑ 148.1%
Financing Cash Flow	$-519.0M	↓ 54.71%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$4.3B	↓ 16.9%
Investing Cash Flow	$-3.3B	↓ 38.07%
Financing Cash Flow	$220.0M	↓ 142.39%

Metlife Technicals Summary

Sell

Neutral

Buy

Metlife is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Metlife, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Metlife, Inc.	0.99%	-2.22%	7.26%	20.63%	105.11%
Manulife Financial Corporation	-4.05%	-0.96%	14.86%	67.43%	98.88%
Aflac Inc.	5.12%	5.87%	1.45%	75.61%	189.35%
Unum Group	-14.13%	-6.39%	28.27%	77.5%	269.17%
Prudential Financial, Inc.	1.73%	-2.13%	-7.0%	7.89%	55.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Metlife, Inc.	13.42	13.42	0.92	8.64	0.16	0.01	0.03	41.52
Manulife Financial Corporation	13.48	13.48	1.06	4.01	0.12	0.01	0.06	27.81
Aflac Inc.	24.42	24.42	0.93	6.85	0.09	0.02	0.02	50.86
Unum Group	8.31	8.31	2.5	8.5	0.14	0.02	0.02	65.76
Prudential Financial, Inc.	23.61	23.61	0.64	13.73	0.06	0.0	0.05	86.9

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Metlife, Inc.	Buy	$52.6B	105.11%	13.42	5.87%
Manulife Financial Corporation	Buy	$51.1B	98.88%	13.48	19.36%
Aflac Inc.	Hold	$57.9B	189.35%	24.42	15.32%
Unum Group	Buy	$11.8B	269.17%	8.31	11.77%
Prudential Financial, Inc.	Hold	$37.7B	55.12%	23.61	2.76%

Metlife Dividend announcements

Metlife Dividends September, 2025
In the quarter ending September,2025. Metlife has declared dividend of $0.57

About Metlife, Inc.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.

Organization	Metlife
Employees	45000
CEO	Mr. Michel Abbas Khalaf
Industry	Finance

Key Management of Metlife, Inc.

Name	Title
Mr. Michel Abbas Khalaf	CEO, President & Director
Mr. Bill Pappas	Executive VP and Head of Global Technology & Operations
Ms. Marlene Beverly Debel B.S., M.B.A.	Executive VP, Chief Risk Officer & Head of Insurance Investments
Mr. Ramy Tadros	Regional President of U.S. Business & Head of MetLife Holdings
Mr. Toby Srihiran Brown	Executive VP, Interim Chief Accounting Officer & Global Head of Reinsurance
Mr. John Arthur Hall	Senior VP & Head of Investor Relations
Ms. Monica M. Curtis	Executive VP & Chief Legal Officer
Ms. Jane Slusark	Chief Communications Officer
Mr. Michael Roberts	Executive VP & Chief Marketing Officer
Ms. Shurawl Sibblies	Executive VP & Chief Human Resources Officer

Important FAQs about investing in MET Stock from India :

What is Metlife share price today?

Metlife share price today is $81.30 as on August 23, 2025 at 12:37 AM IST. Metlife share today touched a day high of $81.87 and a low of $80.08.

What is the 52 week high and 52 week low for Metlife share?

Metlife share touched a 52 week high of $89.05 and a 52 week low of $65.21. Metlife stock price today i.e. August 23, 2025 at 12:37 AM IST is trending at $81.30, lower by 8.7% versus the 52 week high.

How to invest in Metlife Stock (MET) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Metlife on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Metlife Shares that will get you 0.0185 shares as per Metlife share price of $81.30 per share as on August 23, 2025 at 12:37 AM IST.

What is the minimum amount required to buy Metlife Stock (MET) from India?

Indian investors can start investing in Metlife (MET) shares with as little as ₹87.521 or $1 (as of August 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Metlife stock (as per the Rupee-Dollar exchange rate as on August 22, 2025). Based on Metlife share’s latest price of $81.30 as on August 23, 2025 at 12:37 AM IST, you will get 0.1230 shares of Metlife. Learn more about fractional shares .

What are the returns that Metlife has given to Indian investors in the last 5 years?

Metlife stock has given 105.11% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?